Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_provenance.
- NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_assertion wasGeneratedBy ECO_0000203 NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_provenance.
- NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_assertion wasDerivedFrom befree-20150227 NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_provenance.
- NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_assertion SIO_000772 21703428 NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_provenance.
- NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_assertion evidence source_evidence_literature NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_provenance.
- NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_assertion description "[Comparable in efficacy with Bevacizumab, monotherapy with the PAR1 i3 loop pepducin P1pal-7 provided significant 75% inhibition of lung tumor growth in nude mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974464.RAhWzMtmvGkBIx3ww9X70dOqzU1LAqbVpfCf_VrgB52m0130_provenance.